These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24459840)

  • 21. Impact of host and environmental factors on β-glucuronidase enzymatic activity: implications for gastrointestinal serotonin.
    Walsh J; Olavarria-Ramirez L; Lach G; Boehme M; Dinan TG; Cryan JF; Griffin BT; Hyland NP; Clarke G
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G816-G826. PubMed ID: 32146834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
    Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
    Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.
    Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S
    Digestion; 2012; 86(1):6-11. PubMed ID: 22688504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
    Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota in pediatric inflammatory bowel disease.
    Schwiertz A; Jacobi M; Frick JS; Richter M; Rusch K; Köhler H
    J Pediatr; 2010 Aug; 157(2):240-244.e1. PubMed ID: 20400104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal beta-defensin-2 in children with inflammatory bowel diseases.
    Kapel N; Benahmed N; Morali A; Svahn J; Canioni D; Goulet O; Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):117-20. PubMed ID: 19172136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?
    Malin M; Verronen P; Mykkänen H; Salminen S; Isolauri E
    Br J Rheumatol; 1996 Jul; 35(7):689-94. PubMed ID: 8670606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Manifestation of Inflammatory Bowel Disease Following Subcutaneous Autovaccination.
    Raithel M; Weidenhiller M; Hahn M; Hagel A; Bechthold C; Neurath MF; Rieker RJ; Stein J
    J Crohns Colitis; 2015 Sep; 9(9):802-5. PubMed ID: 26088200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
    Roszak D; Gałęcka M; Cichy W; Szachta P
    Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tryptase activity in colon mucosal samples of children with inflammatory bowel disease].
    Popadiuk S; Renke J; Gleń J; Landowski P; Kamińska B; Szlagatys-Sidorkiewicz A; Szumera M; Ulko P; Korzon M
    Med Wieku Rozwoj; 2006; 10(2):437-43. PubMed ID: 16825714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of incubation pH on the activity of rat and human gut flora enzymes.
    Mallett AK; Bearne CA; Rowland IR
    J Appl Bacteriol; 1989 May; 66(5):433-7. PubMed ID: 2502531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities.
    Flores R; Shi J; Gail MH; Ravel J; Goedert JJ
    Eur J Clin Invest; 2012 Aug; 42(8):848-54. PubMed ID: 22409163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases.
    Blais Lecours P; Marsolais D; Cormier Y; Berberi M; Haché C; Bourdages R; Duchaine C
    PLoS One; 2014; 9(2):e87734. PubMed ID: 24498365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of health-related quality of life in children with inflammatory bowel disease, their parents, and physician as measured by a visual analog scale.
    Teitelbaum JE; Rajaraman RR; Jaeger J; Para S; Rakitt T
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):594-7. PubMed ID: 23752079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children.
    Krzesiek E
    Adv Clin Exp Med; 2015; 24(5):815-22. PubMed ID: 26768632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-degradation products and bacterial enzyme activities in faeces of breast-fed and formula-fed infants.
    Heavey PM; Savage SA; Parrett A; Cecchini C; Edwards CA; Rowland IR
    Br J Nutr; 2003 Apr; 89(4):509-15. PubMed ID: 12654169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.
    Roka K; Roma E; Stefanaki K; Panayotou I; Kopsidas G; Chouliaras G
    J Crohns Colitis; 2013 Nov; 7(10):797-802. PubMed ID: 23207168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.